CCA
TVGN icon

Castle Creek Arbitrage’s Tevogen Bio Holdings TVGN Stock Holding History

Castle Creek Arbitrage’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,998
Closed -$1.62M – 71
2023
Q3 		$1.62M Buy
+2,998
New +$1.62M 0.38% 61
2023
Q1 		– Sell
-8,000
Closed -$4.13M – 474
2022
Q4 		$4.13M Buy
+8,000
New +$4.09M 0.36% 74

Other funds holding TVGN

MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Castle Creek Arbitrage's TVGN Position: Q4 2023 in Review

Castle Creek Arbitrage sold out of Tevogen Bio Holdings (TVGN) in Q4 2023, closing a stake of 2,998 shares — an estimated $1.62M sold.

Castle Creek Arbitrage first reported a position in TVGN in Q4 2022 and held it in 2 quarters. The position peaked at $4.13M in Q4 2022. 6 funds tracked by Wall St. Rank hold TVGN as of Q4 2023.

  • Castle Creek Arbitrage reported no remaining Tevogen Bio Holdings position as of Q4 2023 after selling out during the quarter.
  • Castle Creek Arbitrage sold 2,998 Tevogen Bio Holdings shares in Q4 2023, an estimated $1.62M.
  • Castle Creek Arbitrage first reported a position in Tevogen Bio Holdings in Q4 2022 and held it in 2 quarters.
  • Castle Creek Arbitrage's Tevogen Bio Holdings position peaked at $4.13M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q4 2023.

Based on Castle Creek Arbitrage's 13F filing for Q4 2023.